Abivax S.A. (AAVXF) SEC Filings — 2025
10 SEC filings for Abivax S.A. (AAVXF) in 2025.
Filings
- Abivax S.A. 6-K Filing — 6-K · Dec 15, 2025
- Abivax S.A. Files 6-K for H1 2025 Financials — 6-K · Sep 8, 2025
- Abivax SA Enters Underwriting Agreement for Securities Sale — 6-K · Jul 24, 2025
- Abivax SA Announces Positive Phase 3 UC Trial Results — 6-K · Jul 22, 2025
- Abivax SA Shareholder Meeting Results Confirmed — 6-K · Jun 11, 2025
- Abivax S.A. Q1 2025 Financials Filed — 6-K · Jun 2, 2025
- Abivax Completes Enrollment for Ulcerative Colitis Phase 3 Trials — 6-K · Apr 29, 2025
- Abivax Announces AGM Details and Board Appointment — 6-K · Apr 22, 2025
- Abivax S.A. Files 2024 Annual Report — 20-F · Mar 24, 2025
- Abivax Obefazimod Trial Data Published in The Lancet — 6-K · Jan 10, 2025